It is still conspicuous that some cancer entities such as SQCCs of various sites and colorectal, pancreatic, gallbladder, pulmonary, or cervical adenocarcinomas did often show high STING expression levels while other entities such as prostatic adenocarcinomas, renal cell carcinomas, or neuroendocrine neoplasm were less frequently STING-positive. The gene discussed is STING1; the disease is neuroendocrine neoplasm.